Form 4 for ABT Abbott Laboratories
Accepted 2022-03-02 00:00:00 ET · period of report 2022-02-28 · accession 0001415889-22-002203 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-02 | 2022-02-28 | ABT | Watkin Jared | SVP | F - Tax | $122.41 | -6,759 | 67.6K | -9% | -$827.4K | |
| 2022-03-02 | 2022-03-01 | ABT | Watkin Jared | SVP | S - Sale | $118.10 | -1,038 | 66.5K | -2% | -$122.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2022-02-28 | F | D | 6,759 | $122.41 | 67,583 | D | — | — | |
| 2 | Common | Common shares without par value | 2022-03-01 | S | D | 1,038 | $118.10 | 66,545 | D | — | — |